Selected Publications

Fraint E, Abdel-Azim H, Bhatt N, Broglie L, Chattha A, Kohorst M, Ktena Y, Lee M, Long S, Qayed M, Sharma A, Stefanski H, Vatsayan A, Wray L, Hamadani M, Carpenter P: Evaluation of children with malignancies for blood and marrow transplantation: A report from the ASTCT Committee on Practice Guidelines. Transplantation and Cellular Therapy Page: doi: 10.1016, February 2023 Notes: epub ahead of print.

Aredas B, Wray L, Ellison A et al.: Doing The Work To Create A Diverse, Equitable and Anti-racist Environment in Academic Medicine. Pediatric Academic Societies Meeting, Denver, CO April 2022 Notes: Podium presentation.

Ruiz J, Wray L, Kline C et al. : Implementing a Diversity, Equity and Antiracism Curriculum in a single institution Cancer Center. Pediatric Academic Societies Meeting, Denver, CO April 2022 Notes: Podium presentation.

Leahy AB, Newman H, Li Y, Liu H, Myers R, DiNofia A, Dolan JG, Callahan C, Baniewicz D, Devine K, Wray L, Aplenc R, June CH, Grupp SA, Rheingold SR, Maude SL: CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials. The Lancet Haematology 8(10): e711-e722, October 2021.

Myers R, Li Y, Leahy A, Barrett D, Teachey D, Callahan C, Fasano C, Rheingold S, DiNofia A, Wray L, Aplenc A, Baniewicz D, Liu H, Shaw P, Pequignot E, Getz K, Brogdon J, Fesnak A, Siegel D, Davis M, Bartoszek C, Lacey S, Hexner E, Chew A, Wertheim G, Levine B, June C, Grupp S, Maude S: Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T cells in CAR-Naïve and CAR-Exposed Children and Young adults with Relasped/Refractory Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 39(27): 3044-3055, September 2021.

Stephan Kadauke, MD, PhD; Regina M. Myers, MD; Yimei Li, PhD; Richard Aplenc, MD, PhD; Diane Baniewicz, CRNP; David M. Barrett, MD, PhD; Allison Barz Leahy, MD; Colleen Callahan, CRNP; Joseph G. Dolan, MD; Julie C. Fitzgerald, MD, PhD; Whitney Gladney, PhD; Simon F. Lacey, PhD; Hongyan Liu, PhD; Shannon L. Maude, MD, PhD; Regina McGuire, BA; Laura S. Motley, RN; David T. Teachey, MD; Gerald B. Wertheim, MD, PhD; Lisa Wray, MD; Amanda M. DiNofia, MD; and Stephan A. Grupp, MD, PhD: Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial. Journal of Clinical Oncology 39(8): 920-930, March 2021.

Fraint E, Holuba M, Wray L: Pediatric Hematopoietic Stem Cell Transplant. Pediatrics in Review 41(11): 609-611, November 2020.

Leahy AB, Stanley KJ, Myers RM, DiNofia AM, Wray L, Rheingold SR, Callahan C, Baniewicz D, Barry A, Patino M, Hunger SH, Grupp S, Barrett DM, Maude SL: Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell Therapy. American Society of Hematology Annual Meeting, Orlando, FL 2019 Notes: Poster presentation.

Fraint E, Wray L, Miller E.: Emotional Reactions and Coping Mechanisms of Pediatric Residents to Patient Deaths. American Academy of Pediatrics, Chicago, IL September 2017 Notes: Poster presentation.

Vujkovic M, Kershenbaum A, Wray L, McWilliams T, Cannon S, Devidas M, Stork L, Aplenc R: Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952. Leukemia Research Reports 4(2): 47-50, July 2015.